EXOZ - Invizyne Technologies, Inc. Broker Consensus Forecast

Corporate company logo of Invizyne Technologies (EXOZ)

eXoZymes Inc (EXOZ) is an innovative startup developing cell-free enzymes through R&D partnerships with major corporations. This chart reflects the current market value on the GURU.Markets platform at 0.00. The company generates revenue by implementing eco-friendly biomanufacturing systems for fuels and pharmaceuticals. Furthermore, the development of biocatalysts for various industries allows the business to effectively mitigate potential regulatory threats.

EXOZ Invizyne Consensus Target (02/13/2025 - 11/11/2026)
Flagship merchandise of Invizyne

The market consensus target for eXoZymes Inc (EXOZ) reflects the capitalization potential of a biotechnology business whose innovations in cell-free fermentation promise high margins and stable free cash flow. This indicator represents a weighted average of target prices from leading analysts, aggregating market expectations into a single trajectory to objectively assess the company's fundamental value and minimize the impact of short-term volatility.

Competitors of eXoZymes Inc

HLN - Average Forecast Price|Kenvue - Consensus Target|VRNA: Broker Consensus Forecast|MENS - Price Target Chart|Average Forecast Price Ligand Corp|AMRX (Amneal Pharmaceuticals) - Consensus Target|Forecast Levels Chart PRGO (perrigo.com)|Price Target Chart Alvotech SA|Liquidia Corp - Forecast Levels Chart|Analyst Consensus Forecast GLPG|ANIP (ANI Pharmaceuticals Corp) - Fair Value Consensus|Analyst Consensus Forecast MNKD (MannKind Corporation)|Analyst Consensus Forecast amphastar.com AMPH|PCRX - Price Target Chart|Fair Value Consensus SPRY (ARS Pharmaceuticals Inc)|Theravance (TBPH) - Price Target Chart|Consensus Target Aquestive Corp|SCPH (scPharmaceuticals, Inc.) - Analyst Consensus Forecast|Analyst Consensus Forecast Tectonic|Consensus Target TNXP (Tonix Pharmaceuticals Holding Corp.)|SXTC (sxtchina.com) - Fair Value Consensus|Price Target Chart Eupraxia Pharmaceuticals Inc. EPRX|BioHarvest Sciences Inc (BHST) - Average Forecast Price|ORMP: Consensus Target|Entera Bio Ltd. - Analyst Forecast Prices|HYFT: Analyst Consensus Forecast|ABVC BioPharma Inc. - Fair Value Consensus|CPIX (Cumberland Pharma) - Analyst Consensus Forecast|Average Forecast Price Quantum BioPharma Corp QNTM|Price Target Chart FibroGen, Inc. (FGEN)|TELO (telomirpharma.com) - Fair Value Consensus|Analyst Consensus Forecast RANI (Rani Therapeutics Holdings, Inc.)|Synergy CHC Corp. (SNYR) - Average Forecast Price|RLYB: Consensus Target|LEXX (Lexaria Bioscience) - Broker Consensus Forecast|Pulmatrix, Inc. (PULM) - Price Target Chart|Average Forecast Price Pheton Holdings (PTHL)|Consensus Target APM|Lyra Therapeutics Inc. - Forecast Levels Chart|Consensus Target IBO (Impact BioMedical Inc)|TNFA - Average Forecast Price|Price Target Chart cbdMD YCBD|PRFX - Consensus Target|Auris Medical - Analyst Consensus Forecast|Average Forecast Price Lipella Pharmaceuticals Inc|Optinose (OPTN) - Price Target Chart|PIRS - Analyst Median Target|Consensus Target PROC|PTPI: Fair Value Consensus|Analyst Consensus Forecast QLI|Analyst Median Target Acelyrin Inc.|Price Target Chart TFF Pharma TFFP